Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients.

Douglas R FarquharMaheer M MasoodNicholas R LenzeJason TasoulasSiddharth ShethCatherine LumleyJeffrey BlumbergWendell G YarbroughJose P ZevallosMark C WeisslerAdam M ZanationTrevor G HackmanAndrew F Olshan

Published in: Head & neck (2023)

For patients in this population-based cohort, those traveling greater distances for treatment of HPV-negative HNSCC had improved OS. This analysis suggests that the benefits of coordinated, multidisciplinary care may outweigh the barriers of travel burden for these patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
peritoneal dialysis
prognostic factors
high grade
risk factors
patient reported outcomes
quality improvement
chronic pain
health insurance
cervical cancer screening